Developing new non-antibiotic treatments that limit damage and accelerate recovery from deep tissue infections
Return to Listing
Enabled research team to capitalize on unique detection method for hydrogen sulfide to develop non-antibiotic treatments that effectively limit damage and speed recovery from infections resulting from contact with the gas
Documented progress in cloning and expressing the bacteria and human versions of enzymes that produce hydrogen sulfide gas
Effectively excluded current known inhibitors of hydrogen sulfide production as therapeutic agents - they are far more toxic to humans than to bacteria. The team identified vitamin B12 as a novel binder of hydrogen sulfide, a safe inhibitor in humans yet to be tested in bacteria
8701 W Watertown Plank Road, Milwaukee, WI 53226-0509 (414) 955-4350
Contact Us
Subscribe
Governance and Reporting
Funding Opportunities
Maps & Directions
©2021 MEDICAL COLLEGE OF WISCONSIN. ALL RIGHTS RESERVED | MCW.EDU | TERMS & PRIVACY | NON-DISCRIMINATION NOTICE